P
Progyny, Inc.
PGNY · NASDAQ · Healthcare · 2.1B
Closing price
$27.93
+0.36% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
40.7×
Price / net assetsP/B
4.6×
Enterprise value / EBITDAEV/EBITDA
22.9×
Free cash flow yieldFCF yield
8.1%
Return on equityROE
11.3%
Operating margin
6.6%
Net debt / EBITDAbalance-sheet strength
-0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.